Horizon Pharma reported $201M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Adamas Pharmaceuticals ADMS:US 527K 142K
Aerie Pharmaceuticals AERI:US $ 6.18M 0.52M
ALKERMES ALKS:US 53.12M 12.1M
Amgen AMGN:US $ 1637M 147M
Antares Pharma ATRS:US $ 16.44M 0M
AstraZeneca AZN:LN 2193M 273M
Bristol Myers Squibb BMY:US $ 2451M 52M
Coherus Biosciences CHRS:US $ 16.7M 9.18M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Horizon Pharma HZNP:US $ 201M 100.63M
JAZZ PHA JAZZ:US $ 119.19M 79M
Merk MRK:US $ 2684M 771M
Novartis NOVN:VX SF 3754M 79M
Pacira Pharmaceuticals PCRX:US $ 35.25M 3.9M
Perrigo Ordinary Shares PRGO:US $ 632.1M 9.5M
Pfizer PFE:US $ 6992M 2820M
Prestige Brands PBH:US $ 110.17M 9.46M
Revance Therapeutics RVNC:US $ 5.43M 1.21M
Supernus Pharmaceuticals SUPN:US $ 25.03M 10.07M
Takeda 4502:JP Y 241264M 12182M
Teva Pharmaceutical Industries TEVA:US $ 1987M 76M
Valeant Pharmaceuticals VRX:CN $ 612M 38M
Xeris Pharmaceuticals Inc XERS:US $ 3.38M 1.56M
Zoetis ZTS:US $ 564M 21M